Registry studying bacteria patterns in suspected small bowel overgrowth
Part of Digestive system clinical trials.
This is a research registry that collects small-bowel fluid samples from people being tested for “SIBO” (an overgrowth of bacteria in the small intestine). It aims to describe what bacteria are present and how results differ between people with suspected SIBO and others having similar tests for other reasons.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are having a small-bowel aspiration (a sample taken from the small intestine) for suspected SIBO
- You have not taken antibiotics in the past 30 days (unless your doctor is repeating aspiration for clearance)
- You have not taken probiotics in the past 30 days
- You have not used a colon-cleaning prep in the past 1 month
- You can safely have an upper endoscopy (or the study test) if needed
- You can give informed consent (and you’re not pregnant)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a methane and hydrogen breath test to help diagnose small intestinal bacterial overgrowth (SIBO) in people with digestive symptoms compared to healthy individuals. If you have ongoing belly problems like bloating, pain, or diarrhea, this test might help find the cause.
This study tests how Rifaximin (a medicine for SIBO) affects the bacteria and other substances in your gut. You'll swallow a small capsule that collects samples as it travels through your digestive system, so researchers can see how your gut changes during treatment.
This early study tests whether fecal microbiota transplant (a stool donation placed into the gut) is safe and practical for children with small intestinal bacterial overgrowth (SIBO). It may help reduce SIBO symptoms, but the main goal is to see if the treatment and study steps work well.
This study tests a probiotic pill for people with bothersome bloating and an abnormal hydrogen breath test. It aims to see if the probiotic helps improve gut symptoms.
This study tests the SIMBA capsule to learn how gut bacteria (dysbiosis) relate to digestive conditions. It may help researchers better understand these conditions and how the capsule can be used safely.
This study enrolls healthy adults to build a registry and biobank (collection of samples). It tests whether collecting information and biological samples from people without symptoms can help researchers understand normal stomach and esophagus function.
Hear when a new Functional Dyspepsia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.